Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

By Thariani Rahber   Henry Norah Lynn   Ramsey Scott D   Blough David K   Barlow Bill   Gralow Julie R   Veenstra David L  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 3, 2013-05 ,pp. : 325-334

Future Medicine

Access to resources Recommend Favorite

Effects of Mindfulness-Based Stress Reduction Intervention on Psychological Well-being and Quality of Life: Is Increased Mindfulness Indeed the Mechanism?

By Nyklíček Ivan  

Annals of Behavioral Medicine, Vol. 35, Iss. 3, 2008-06 ,pp. : 331-340

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer screening: an ethical dilemma, or an opportunity for openness?

By Blennerhassett Mitzi  

Quality in Primary Care, Vol. 21, Iss. 1, 2013-04 ,pp. : 39-42

Radcliffe Press

Access to resources Recommend Favorite

Early Detection of Breast Cancer: New Biomarker Tests on the Horizon?

By Jotwani Aparna C.  

Molecular Diagnosis & Therapy, Vol. 13, Iss. 6, 2009-12 ,pp. : 349-357

Adis International

Access to resources Recommend Favorite

Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

By Fleeman Nigel   Payne Katherine   Newman William G   Howell Sacha J   Boland Angela   Oyee James   Saborido Carlos Martin   Santander Ana Fernández   Dickson Rumona  

Personalized Medicine, Vol. 10, Iss. 6, 2013-08 ,pp. : 601-611

Future Medicine

Access to resources Recommend Favorite